Clinical Manifestation and Treatment of Allergic Bronchopulmonary Aspergillosis

被引:7
|
作者
Agarwal, Ritesh [1 ]
Muthu, Valliappan [1 ]
Sehgal, Inderpaul S. [1 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Pulm Med, Sect 12, Chandigarh 160012, India
关键词
allergic fungal airway disease; allergic bronchopulmonary mycosis; ABPM; allergic fungal sensitization; corticosteroids; bronchiectasis; RANDOMIZED-TRIAL; CYSTIC-FIBROSIS; ITRACONAZOLE; BRONCHIECTASIS; ASTHMA; IGE; CT; SENSITIZATION; BENRALIZUMAB; OMALIZUMAB;
D O I
10.1055/s-0043-1776912
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Allergic bronchopulmonary aspergillosis (ABPA) is a complex hypersensitivity reaction to airway colonization by Aspergillus fumigatus in patients with asthma and cystic fibrosis. The pathophysiology of ABPA involves a complex interplay between the fungus and the host immune response, which causes persistent inflammation and tissue damage. Patients present with chronic cough, wheezing, and dyspnea due to uncontrolled asthma. Characteristic symptoms include the expectoration of brownish mucus plugs. Radiographic findings often reveal fleeting pulmonary infiltrates, bronchiectasis, and mucus impaction. However, the definitive diagnosis of ABPA requires a combination of clinical, radiological, and immunological findings. The management of ABPA aims to reduce symptoms, prevent disease progression, and minimize the future risk of exacerbations. The treatment approach involves systemic glucocorticoids or antifungal agents to suppress the inflammatory response or fungal growth and prevent exacerbations. Biological agents may be used in patients with severe disease or glucocorticoid dependence. This review provides an overview of the clinical manifestations and current treatment options for ABPA.
引用
收藏
页码:114 / 127
页数:14
相关论文
共 50 条
  • [1] Acute Manifestation of allergic bronchopulmonary Aspergillosis
    Deppe, C.
    Hartert, M.
    Kappes, J.
    PNEUMOLOGIE, 2024, 78 : S3 - S3
  • [2] The treatment of allergic bronchopulmonary aspergillosis
    Chiu, AM
    FRONTIERS IN BIOSCIENCE, 2003, 8 : S243 - S245
  • [3] Allergic bronchopulmonary aspergillosis - Clinical perspectives
    Varkey, B
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 1998, 18 (03) : 479 - +
  • [4] Clinical aspects of allergic bronchopulmonary aspergillosis
    Greenberger, PA
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2003, 8 : S119 - S127
  • [5] Clinical characteristics of allergic bronchopulmonary aspergillosis
    Zhang, Cuiping
    Jiang, Zhilong
    Shao, Changzhou
    CLINICAL RESPIRATORY JOURNAL, 2020, 14 (05): : 440 - 446
  • [6] Tezepelumab treatment for allergic bronchopulmonary aspergillosis
    Ogata, Hiroaki
    Sha, Kachi
    Kotetsu, Yasuaki
    Enokizu-Ogawa, Aimi
    Katahira, Katsuyuki
    Ishimatsu, Akiko
    Taguchi, Kazuhito
    Moriwaki, Atsushi
    Yoshida, Makoto
    RESPIROLOGY CASE REPORTS, 2023, 11 (05):
  • [7] CORTISONE TREATMENT IN ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
    GRZINCICH, GL
    GRANDI, F
    CORRADI, C
    VIRDIS, R
    CARBOGNANI, L
    BATTISTINI, A
    RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1982, 8 (04): : 560 - 560
  • [8] Diagnosis and treatment of allergic bronchopulmonary aspergillosis
    Nichole T. Tanner
    Marc A. Judson
    Current Fungal Infection Reports, 2008, 2 (4)
  • [9] Omalizumab treatment in allergic bronchopulmonary aspergillosis
    Sousa, F.
    Mendes, A.
    Barbosa, M.
    ALLERGY, 2010, 65 : 552 - 552
  • [10] TREATMENT OF BRONCHOPULMONARY ASPERGILLOSIS WITH ALLERGIC MANIFESTATIONS
    ANTONOV, VB
    MITROFANOV, VS
    SOBOLEV, AV
    YAROBKOVA, ND
    TERAPEVTICHESKII ARKHIV, 1994, 66 (03) : 61 - 63